SPONSOR
Fate Therapeutics
Total Trials
3
Recruiting
3
Phases
Phase 1, Phase 1, Phase 2
Conditions studied: Advanced Solid TumorANCA-Associated Vasculitis (AAV)Idiopathic Inflammatory Myositis (IIM)Rheumatoid Arthritis (RA)Systemic Lupus Erythematosus (SLE)Systemic Sclerosis (SSc)Non-Small Cell Lung CancerColorectal CancerBreast CancerOvarian Cancer
Fate Therapeutics is a clinical research sponsor with 3 registered studies on ClinicalTrials.gov, of which 3 are actively recruiting participants. Research covers conditions including Advanced Solid Tumor, ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA).
The trial portfolio spans Phase 1, Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Fate Therapeutics
How many clinical trials has Fate Therapeutics sponsored?
ClinicalMetric currently tracks 3 clinical trials sponsored by Fate Therapeutics, of which 3 are actively recruiting participants. These trials cover conditions including Advanced Solid Tumor, ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM). Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Fate Therapeutics research focus on?
Fate Therapeutics clinical trials span Advanced Solid Tumor, ANCA-Associated Vasculitis (AAV), Idiopathic Inflammatory Myositis (IIM), Rheumatoid Arthritis (RA), Systemic Lupus Erythematosus (SLE), and additional conditions. The research pipeline includes Phase 1, Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Fate Therapeutics clinical trial?
To participate in a Fate Therapeutics trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Fate Therapeutics trials with current recruitment status updated daily.
Clinical Trials by Fate Therapeutics
NCT06241456 Phase 1
Recruiting
FT825/ONO-8250, an Off-the-Shelf, HER2 CAR-T, With or Without Monoclonal Antibodies in Advanced Solid Tumors
Advanced Solid Tumor
NCT07800871 Phase 1, Phase 2
Recruiting
FT839 in Autoimmune Diseases
ANCA-Associated Vasculitis (AAV)
NCT07216105 Phase 1
Recruiting
FT836 With or Without Chemotherapy and/or Monoclonal Antibodies, in Participants With Advanced Solid Tumors
Non-Small Cell Lung Cancer
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology